Peter E. Boyd, See Remarks at Aquestive Therapeutics, Inc. (AQST), sold 10,000 shares at $6.30 ($63K) on 2025-09-26, disclosed to the SEC on 2025-09-29.
Scheduled sale ($63k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AQST | SELL | 2025-09-08 | $80K | — | Filing → |
| AQST | BUY | 2022-06-15 | $4K | — | Filing → |
| AQST | BUY | 2022-06-10 | $2K | — | Filing → |